Basics ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.23B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 4.61% Avg Daily Range (30 D): $0.08 | 3.28% Avg Daily Range (90 D): $0.11 | 3.84% Institutional Daily Volume Avg Daily Volume: 3.16M Avg Daily Volume (30 D): 8.44M Avg Daily Volume (90 D): 6.77M Trade Size Avg Trade Size (Sh.): 199 Avg Trade Size (Sh.) (30 D): 394 Avg Trade Size (Sh.) (90 D): 311 Institutional Trades Total Inst.Trades: 1,080 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $.96M Avg Inst. Trade (90 D): $1.25M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.95M Avg Closing Trade (30 D): $.92M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 343.39K         News Aug 23, 2024 @ 8:30 PM HCW Biologics Reports Second Quarter 2024 Financia... Source: N/A Jun 26, 2024 @ 1:41 PM ImmunityBio (IBRX) Gains 17% in the Past Week: Her... Source: Zacks Equity Research Mar 20, 2024 @ 3:41 PM Sportradar Group Posts Upbeat Earnings, Joins King... Source: Avi Kapoor Feb 26, 2024 @ 6:57 PM Why Freshpet Shares Are Trading Higher By Around 1... Source: Avi Kapoor Feb 26, 2024 @ 1:18 PM Why Intuitive Machines Shares Are Trading Lower By... Source: Avi Kapoor Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.15 $-.12 Diluted EPS $-.15 $-.14 Revenue $ $ 16.52M $ 6.11M Gross Profit $ $ 16.46M $ Net Income / Loss $ $ -129.67M $ -85.75M Operating Income / Loss $ $ -64.43M $ -80.25M Cost of Revenue $ $ .06M $ M Net Cash Flow $ $ -82.76M $ -18.15M PE Ratio